|
⚲
|
| Keyboard |
| Kucinski Keith A
✚
|
|
|---|---|
| CIK # | 0001763405 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001763405] | |
| 4 | [0001763405] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kucinski Keith A | |
| Matinas BioPharma Holdings Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Matinas BioPharma Holdings Inc MTNB
Stock Option (right to Buy) · derivative
|
2023-12-15 | Grant | 1,000,000 | $0.00 | |
|
Matinas BioPharma Holdings Inc MTNB
Stock Option (right to Buy) · derivative
|
2022-12-20 | Grant | 625,000 | $0.00 | |
|
Matinas BioPharma Holdings Inc MTNB
Stock Option (right to Buy) · derivative
|
2021-12-14 | Grant | 500,000 | $0.00 | |
|
Matinas BioPharma Holdings Inc MTNB
Stock option (right to buy) · derivative
|
2021-01-01 | Grant | 500,000 | $0.00 | |
|
Matinas BioPharma Holdings Inc MTNB
Stock option (right to buy) · derivative
|
2020-06-17 | Grant | 175,000 | $0.00 | |
|
Matinas BioPharma Holdings Inc MTNB
Stock option (right to buy) · derivative
|
2020-01-01 | Grant | 350,000 | $0.00 | |
|
Matinas BioPharma Holdings Inc MTNB
Common Stock, par value $0.0001 per share
|
2019-11-25 | Buy | 58,000 | $1.23 | 71,340 |
|
Matinas BioPharma Holdings Inc MTNB
Common Stock, par value $0.0001 per share
|
2019-11-22 | Buy | 36,500 | $1.20 | 43,800 |
|
Matinas BioPharma Holdings Inc MTNB
Stock option (right to buy) · derivative
|
2019-02-11 | Grant | 275,000 | $0.00 | |
|
Matinas BioPharma Holdings Inc MTNB
Stock option (right to buy) · derivative
|
2019-01-02 | Grant | 250,000 | $0.00 |